ME-143, a novel inhibitor of tumor-specific NADH oxidase (tNOX): Results from a first-in-human phase I study.
暂无分享,去创建一个
Suzanne F. Jones | J. Bendell | H. Burris | J. Infante | C. Kurkjian | S. Pant | O. Moreno | K. Moore | R. Mass
暂无分享,去创建一个
Suzanne F. Jones | J. Bendell | H. Burris | J. Infante | C. Kurkjian | S. Pant | O. Moreno | K. Moore | R. Mass